Search
PUREGON 100 UI / 0.5 ML IM ou SC, Solution Injectable
Details
| --- | Description |
|---|---|
| Pack | Boîte de 5+5 |
| Strength (Dosage) | 100 UI / 0.5 ML |
| Laboratory | MSD MAROC |
| Ingredients | Follitropine bêta |
| Therapeutic class | Gonadotrophine, rhFSH-beta |
| ATC code | G03GA06 |
| PPH | $175.00 |
| PPV | $200.00 |
| Refundable | No |
| Refund base | $0.00 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Chez les femmes adultes : Puregon est indiqué pour le traitement de l’infertilité féminine dans les situations cliniques suivantes : # Anovulation (y compris le syndrome des ovaires polykystiques - SOPK) chez les femmes ne répondant pas au traitement par le citrate de clomifène. # Hyperstimulation ovarienne contrôlée pour induire le développement de follicules multiples dans le cadre des programmes de procréation médicalement assistée [par exemple, fécondation in vitro avec transfert d'embryon (FIVETE), transfert de gamètes dans les trompes (GIFT), injection intracytoplasmique de spermatozoïde (ICSI)]. Chez les hommes adultes : # Déficience de la spermatogenèse due à un hypogonadisme hypogonadotrope |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem